Research Article
Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer
Article first published online: 7 FEB 2012
DOI: 10.1002/mc.21881
Copyright © 2012 Wiley Periodicals, Inc.
Issue

Molecular Carcinogenesis
Early View (Online Version of Record published before inclusion in an issue)
Additional Information
How to Cite
Alvarez, C., Tapia, T., Cornejo, V., Fernandez, W., Muñoz, A., Camus, M., Alvarez, M., Devoto, L. and Carvallo, P. (2012), Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer. Mol. Carcinog.. doi: 10.1002/mc.21881
Publication History
- Article first published online: 7 FEB 2012
- Manuscript Accepted: 10 JAN 2012
- Manuscript Revised: 26 OCT 2011
- Manuscript Received: 5 MAY 2011
Keywords:
- hereditary breast cancer;
- BRCAX;
- biopsies;
- tumor suppressor gene;
- promoter hypermethylation;
- protein expression
Abstract
Promoter hypermethylation is gaining strength as one of the main mechanisms through which tumor suppressor genes are silenced during tumor progression. Three tumor suppressor genes are frequently found methylated in their promoter, in concordance with absence of expression, RASSF1A, SLIT2, and WIF1. In addition, a previous array-CGH analysis from our group showed that these genes are found in deleted genomic regions observed in hereditary breast cancer tumors. In the present work we analyzed the methylation status of these three tumor suppressor gene promoters in 47 hereditary breast cancer tumors. Promoter methylation status analysis of hereditary breast tumors revealed high methylation frequencies for the three genes (67% RASSF1A, 80% SLIT2, and 72% WIF1). Additionally, the presence of methylated PCR products was associated with absence of protein expression for the three genes and statistically significant for RASSF1A and WIF1. Interestingly, methylation of all the three genes was found in 4 out of 6 grade I invasive ductal carcinoma tumors. Association between RASSF1A methylation and DCIS tumors was found. These results suggest that silencing of these tumor suppressor genes is an early event in hereditary breast cancer, and could be a marker for pre-malignant phenotypes. © 2012 Wiley Periodicals, Inc.

1098-2744/asset/MC_left.gif?v=1&s=a556feb61d2679d84abfca84c413171f17d27f7e)
1098-2744/asset/MC_centre.gif?v=1&s=bb43877f0d0e0160867f47a54d7bcb7e5c431bb0)
1098-2744/asset/MC_right.gif?v=1&s=027d4f6882bb87a19b63005e29bd7ceaf329c50f)